Phenytoin

CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Abacavir, Abiraterone, Acitretin, Afatinib, Amiodarone, Amitriptyline, Amlodipine, Amprenavir, Apixaban, Apremilast, Aprepitant, Artemether/Lumefantrine, Beclomethasone, Bictegravir/Emtricitabine/Tenofovir Alafenamide, Boceprevir, Brigatinib, Brivaracetam, Buprenorphine, Cabazitaxel, Cabozantinib, Caffeine, Calcium, Capecitabine, Caspofungin, Cefazolin, Cenobamate, Ceritinib, Chloramphenicol, Cimetidine, Ciprofloxacin, Citalopram, Clobazam, Clorazepate, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Cobimetinib, Colesevelam, Copanlisib, Crizotinib, Cyclosporine, Cyproterone, Dabigatran, Daclatasvir, Darunavir, Dasatinib, Deferasirox, Deflazacort, Delavirdine, Dexamethasone, Diazoxide, Disulfiram, Dopamine, Doravirine, Doravirine/Lamiduvine/Tenofovir Disoproxil, Doxycycline, Dronedarone, Efavirenz, Elbasvir & Grazoprevir, Eliglustat, Emtricitabine/Rilpivirine/Tenofovir Alafenamide, Enzalutamide, Erlotinib, Eslicarbazepine, Ethosuximide, Etravirine, Everolimus, Ezogabine, Fesoterodine, Flibanserin, Floxuridine, Fluconazole, Flunisolide, Fluoxetine, Fosamprenavir, Fostemsavir, Gefitinib, Gold & Gold Compounds, Hydrocortisone, Ibrexafungerp, Ibrexafungerp, Ibrutinib, Idelalisib, Imatinib, Indinavir, Influenza Vaccine, Isoniazid, Isotretinoin, Isradipine, Itraconazole, Ivabradine, Ixabepilone, Ixazomib, Lacosamide, Lapatinib, Ledipasvir & Sofosbuvir, Leflunomide, Letermovir, Levodopa, Levomepromazine, Levonorgestrel, Lisdexamfetamine, Lomustine, Lopinavir, Lumateperone, Meperidine, Metformin, Methsuximide, Methylprednisolone, Metronidazole, Midazolam, Midostaurin, Mifepristone, Mivacurium, Naldemedine, Nelfinavir, Neratinib, Nifedipine, Nilotinib, Nilutamide, Nintedanib, Olaparib, Oliceridine, Ombitasvir/Paritaprevir/Ritonavir, Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir, Omeprazole, Ondansetron, Osimertinib, Oxcarbazepine, Oxtriphylline, Palbociclib, Paroxetine Hydrochloride, Pemetrexed, Perampanel, Phenylbutazone, Pimavanserin, Piracetam, Ponatinib, Ponesimod, Ponesimod, Posaconazole, Prednisolone, Prednisone, Propranolol, Regorafenib, Rifapentine, Rilpivirine, Riociguat, Risperidone, Ritonavir, Rivaroxaban, Roflumilast, Romidepsin, Saquinavir, Simeprevir, Sofosbuvir, Sofosbuvir & Velpatasvir, Sofosbuvir/Velpatasvir/Voxilaprevir, Solifenacin, Sonidegib, Sorafenib, St John's Wort, Sucralfate, Sunitinib, Tegafur/Gimeracil/Oteracil, Telaprevir, Telithromycin, Temsirolimus, Teniposide, Tenofovir Alafenamide, Tezacaftor/Ivacaftor, Thalidomide, Tiagabine, Ticagrelor, Ticlopidine, Tinidazole, Tipranavir, Tizanidine, Tolvaptan, Triamcinolone, Trimethoprim, Ubrogepant, Ulipristal, Uracil/Tegafur, Valbenazine, Vandetanib, Vemurafenib, Venetoclax, Vigabatrin, Vorapaxar, Voriconazole, Vortioxetine, Zidovudine, Zuclopenthixol

PREGNANCY CATEGORY: D

Aromatic antiepileptic drugs, phenytoin, phenobarbital, carbamazepine and primidone, are a frequent cause of severe cutaneous adverse reactions. A strong genetic association between HLA-B*1502 and phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis has been shown in Han Chinese patients.

Children whose mothers receive phenytoin during pregnancy are born with fetal hydantoin syndrome. The main features of this syndrome are mental and growth retardation, unusual facies, digital and nail hypoplasia, and coarse scalp hair. Occasionally neonatal acne will be present.

Our database has 149 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Visit Informa

Click on the DRUG REVIEW ARTICLE tab (above) to see a review of phenytoin in the Taylor & Francis journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 01/29/2024

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top